Table 3.
Neonatal clinical outcomes, based on severity of maternal COVID-19 symptoms.
| Asymptomatic/mild (n = 59) | Severe (n = 7) | p-value | |||
|---|---|---|---|---|---|
| Sex (n = 66) | |||||
| Male | 23 | (39.0%) | 3 | (42.9%) | > 0.99 |
| Female | 36 | (61.0%) | 4 | (57.1%) | |
| Apgar scores (n = 65) | |||||
| Apgar score 1 | 9.0 | [8.0–9.0] | 9 | [8.0–9.0] | 0.90 |
| Apgar score 5 | 9.0 | [9.0–9.0] | 9 | [9.0–9.0] | > 0.99 |
| Birthweight (n = 66) | 3125.36 ± 622.56 | 2692.29 ± 677.86 | 0.15 | ||
| Admission to the NICU (n = 65) | 9 | (15.5%) | 2 | (28.6%) | 0.34 |
| COVID-19 test (+ /–, n = 66) | |||||
| Not detected | 58 | (98.3%) | 7 | (100%) | > 0.99 |
| Indeterminate or detected | 1 | (1.7%) | 0 | ||
| Not done | 0 | 0 | |||
| Neonatal demise (n = 66) | 0 | 0 | |||
| Fetal demise (n = 66) | 1 | (1.7%) | 0 | > 0.99 | |
*The categorical values are expressed as n (%), the continuous variables are expressed as either median [IQR] or mean ± SD.